Results 251 to 260 of about 410,667 (361)

Diabetic Macular Edema

Asia-Pacific Journal of Ophthalmology, 2020
openaire   +2 more sources

Implementation of A New, Mobile Diabetic Retinopathy Screening Model Incorporating Artificial Intelligence in Remote Western Australia

Australian Journal of Rural Health, Volume 33, Issue 2, April 2025.
ABSTRACT Objective Diabetic retinopathy (DR) screening rates are poor in remote Western Australia where communities rely on outdated primary care‐based retinal cameras. Deep learning systems (DLS) may improve access to screening, however, require validation in real‐world settings.
Qiang Li, Jocelyn J. Drinkwater, Kerry Woods, Emma Douglas, Alex Ramirez, Angus W. Turner   +5 more
wiley   +1 more source

Intravitreal aflibercept for diabetic macular edema: structural and functional improvements. [PDF]

Front Med (Lausanne)
Zhang C, Chen T, Jia R, Gong D, Liu Z, Wu C, Shu X, Han F, Gong B.   +8 more
europepmc   +1 more source

AGREEMENT BETWEEN CLINICIAN AND READING CENTER GRADINGS OF DIABETIC RETINOPATHY SEVERITY LEVEL AT BASELINE IN A PHASE 2 STUDY OF INTRAVITREAL BEVACIZUMAB FOR DIABETIC MACULAR EDEMA [PDF]

, 2008
Ingrid U. Scott, Neil M. Bressler, Susan B. Bressler, David J. Browning, Clement K. Chan, Ronald P. Danis, Matthew D. Davis, Craig Kollman, Haijing Qin   +8 more
openalex   +1 more source

Genotype–Phenotype Correlations in Corneal Dystrophies: Advances in Molecular Genetics and Therapeutic Insights

Clinical &Experimental Ophthalmology, Volume 53, Issue 3, Page 232-245, April 2025.
ABSTRACT Corneal dystrophies are a group of predominantly rare inherited disorders. They are by definition bilateral, relatively symmetrical, and without systemic involvement, affecting corneal transparency and/or refraction. Traditional classification of corneal dystrophies is based on slit‐lamp appearance, affected corneal layer and histological ...
Petra Liskova, Pavlina Skalicka, Lubica Dudakova, Andrea L. Vincent   +3 more
wiley   +1 more source

The Effects of Slow-Release Dexamethasone in the Treatment of Diabetic Macular Edema. [PDF]

Pharmaceutics
Vingolo EM, Mascolo S, Casillo L, Calabro M.   +3 more
europepmc   +1 more source

Recognition of ophthalmology consultation and fundus examination among individuals with diabetes in Japan: A cross‐sectional study using claims‐questionnaire linked data

Diabetes, Obesity and Metabolism, Volume 27, Issue 4, Page 1762-1772, April 2025.
Abstract Aims This study aimed to assess the relationship between individuals' recognition of ophthalmology consultation recommendations, their knowledge of the recommended frequency of diabetic retinopathy screening, and the likelihood of undergoing fundus examinations.
Kouko Yamamoto, Noriko Ihana‐Sugiyama, Takehiro Sugiyama, Takuya Yamaoka, Akiko Wakui‐Kimura, Kenjiro Imai, Naoaki Kuroda, Mitsuru Ohsugi, Kohjiro Ueki, Toshimasa Yamauchi, Nanako Tamiya   +10 more
wiley   +1 more source

Efficacy and safety of intravitreal injection of aflibercept biosimilar for treating diabetic macular edema. [PDF]

Front Med (Lausanne)
Zhai G, Sun C, Zhang X, Su Y.
europepmc   +1 more source

Mechanisms of macular edema: Beyond the surface

Progress in retinal and eye research, 2017
A. Daruich, A. Matet, A. Moulin, L. Kowalczuk, M. Nicolas, A. Sellam, Pierre-Raphaël Rothschild, S. Omri, E. Gélizé, L. Jonet, Kimberley Delaunay, Y. Kozak, M. Berdugo, Min Zhao, P. Crisanti, F. Behar-Cohen   +15 more
semanticscholar   +1 more source

Real‐world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP‐1RA‐based weight‐loss therapies

Diabetes, Obesity and Metabolism, Volume 27, Issue S2, Page 66-88, April 2025.
Abstract Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) have emerged as key agents for weight management, based on their marked efficacy as observed in randomized controlled trials. While still limited, real‐world studies on GLP‐1RA use in populations with obesity are increasingly available. This narrative review discusses contemporary real‐world
Reimar W. Thomsen, Aurélie Mailhac, Julie B. Løhde, Anton Pottegård   +3 more
wiley   +1 more source